Open AccessMeningococcal Surveillance Australia Reporting period 1 January to 31 March 2020
Author(s) -
Monica M Lahra,
Masoud Shoushtari,
Tiffany R Hogan
Publication year - 2020
Publication title -
communicable diseases intelligence
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.616
H-Index - 6
ISSN - 2209-6051
DOI - 10.33321/cdi.2020.44.65
Subject(s) - neisseria meningitidis , nucleic acid amplification tests , communicable disease , medicine , meningococcal disease , meningococcal infections , public health surveillance , public health , pediatrics , virology , biology , pathology , genetics , chlamydia trachomatis , bacteria
The reference laboratories of the National Neisseria Network, Australia, report laboratory data on invasive meningococcal disease (IMD) cases confirmed by laboratory testing using culture- and non-culture-based techniques for the Australian Meningococcal Surveillance Programme. Culture-positive cases, where Neisseria meningitidis is grown from a normally sterile site or from skin lesions, and non-culture-based diagnoses (nucleic acid amplification testing), are defined as IMD by the Public Health Laboratory Network definitions. Data contained in quarterly reports are restricted to a description of the numbers of cases by jurisdiction and serogroup, where known. Some minor corrections to data in Table 1 may be made in subsequent reports if additional data are received. A full analysis of laboratory-confirmed cases of IMD in each calendar year is contained in the AMSP annual report published in Communicable Diseases Intelligence.